Total Funding
25
59
Total FundingGrant raised
Growth Score 25 in past quarter
-9 pts
Heat Score 59 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
124857
BioTherapeutics Inc. (BTI) is a pre-clinical stage company
- Josep Bassaganya-Riera: CEO, Executive Chairman of the Board, President & FounderPast Role: Landos Biopharma, Chairman of the Board, President & CEO
- Raquel Hontecillas: Chief Scientific Officer
About the Company
BioTherapeutics Inc. (BTI) is a pre-clinical stage company developing novel small-molecule drugs to treat inflammation associated with autoimmune related disorders and type 2 diabetes (T2D)

